An Injectable Subcutaneous Colon-Specific Immune Niche for the Treatment of Ulcerative Colitis

Scientists showed, in three mouse models of established ulcerative colitis, that a subcutaneously injected colon-specific immunosuppressive niche reduced inflammation in the animals’ lower gastrointestinal tract.